SCHH vs XLRE: returns, risk and drawdowns compared
Schwab U.S. REIT ETF against Real Estate Select Sector SPDR Fund, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
SCHH
Schwab U.S. REIT ETF
10,000 became
15,062
- A year on average
- +6.7%
- Annual volatility
- 17.9%
- Deepest fall
- −31.5%
- Worst month
- −12.6%
XLRE
Real Estate Select Sector SPDR Fund
10,000 became
14,922
- A year on average
- +6.5%
- Annual volatility
- 18.3%
- Deepest fall
- −32.2%
- Worst month
- −13.2%
SCHH came out ahead by 0.2 percentage points a year from July 2020 to October 2026. XLRE swung more (18.3% against 17.9% a year). The correlation of monthly returns was 0.99: they moved almost in lockstep.
Growth of 10,000: SCHH vs XLRE
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero SCHH had returned more, below zero XLRE. SCHH was ahead in 22% of the 41 three-year periods.
Annualised 3-year return of SCHH minus that of XLRE, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: SCHH −31.5%, XLRE −32.2%.
All the figures
| SCHH | XLRE | |
|---|---|---|
| Annual return (CAGR) | +6.7% | +6.5% |
| Total return | +51% | +49% |
| Annual volatility | 17.9% | 18.3% |
| Deepest fall (month-end) | −31.5% | −32.2% |
| Worst month | −12.6% | −13.2% |
| Best month | +11.6% | +12.5% |
| Positive months | 59% | 58% |
| Best year | 2021: +39.9% | 2021: +46.1% |
| Worst year | 2022: −25.0% | 2022: −26.2% |
| 1-year return | +7.1% | +2.8% |
| 5 years, a year | +1.4% | +1.0% |
| 10 years, a year | +3.1% | — |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half SCHH, half XLRE
| SCHH alone | XLRE alone | 50/50 | |
|---|---|---|---|
| A year on average | +6.7% | +6.5% | +6.6% |
| Annual volatility | 17.9% | 18.3% | 18.1% |
| Deepest fall (month-end) | −31.5% | −32.2% | −31.9% |
| Worst month | −12.6% | −13.2% | −12.9% |
With a correlation of 0.99 the mix behaved almost like either fund alone: its volatility of 18.1% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, SCHH or XLRE?
From July 2020 to October 2026, SCHH returned +6.7% a year and XLRE +6.5% a year, with dividends reinvested. Over rolling 3-year periods SCHH did better in 22% of cases. Past returns do not predict future returns.
Which is riskier, SCHH or XLRE?
Over the same months annual volatility was 17.9% for SCHH and 18.3% for XLRE; the deepest fall from a month-end high was 31.5% and 32.2%, and the worst single month −12.6% and −13.2%.
How correlated are SCHH and XLRE?
The correlation of their monthly returns was 0.99: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both SCHH and XLRE?
Half in each, rebalanced every month, returned +6.6% a year over the same period, with 18.1% annual volatility and a deepest month-end fall of 31.9%.
More comparisons
- SCHH — Schwab U.S. REIT ETFReturns, drawdowns and risk
- XLRE — Real Estate Select Sector SPDR FundReturns, drawdowns and risk
- VNQ vs SCHH
- SCHH vs IYR
- VNQ vs XLRE
- IYR vs XLRE
- Portfolio stress test with custom shocksYour own scenarios, holding by holding
- Portfolio Visualizer alternativesWhich tool fits which job
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.